LL37 (5mg)

Description

A single-component research material supplied for controlled research environments. LL-37 is a synthetic cathelicidin-derived peptide used in research exploring innate immunity, antimicrobial pathways, and wound-healing models in controlled systems.

Composition

• • • LL-37: 5 mg

    • Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

LL37 (5mg)

• • • Characterization of LL-37 in antimicrobial activity assays

    • Studies on immune modulation and inflammatory pathway signaling

    • Evaluation in cell culture and tissue models related to epithelial repair

    • Stability and solubility profiling under laboratory storage conditions

Documentation

• • • COA pending — third-party verification in progress

Important Notice

• • • For research use only

    • Not for human consumption

    • Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• • Lyophilized for transit stability; batch traceable

  • Tamper-evident seal; lot & test date on each vial